Why Do I Hate Myself? Understanding Self-Hate and How to Overcome It

f you are comparing TMS, ketamine, and Spravato for depression, you have probably reached the point where standard antidepressants have not done enough. All three are evidence-based options for treatment-resistant depression, and beyond that they have little in common. TMS is a course of magnetic stimulation delivered while you sit awake in a chair. Ketamine is an anesthetic given by IV, used off-label for depression. Spravato is a nasal spray made from esketamine, one of the two mirror-image forms that make up ketamine, with its own FDA approval and its own rulebook.

‍

None of the three is universally better. They differ in mechanism, speed, setting, and monitoring, and the right one depends on your clinical history and how you respond. Treatment-resistant depression generally means depression that has not adequately improved after at least two antidepressants taken at a proper dose for long enough, and that is the group where all three are most often used.

What Is TMS?

Transcranial magnetic stimulation uses a coil placed against the scalp to deliver focused magnetic pulses to the left dorsolateral prefrontal cortex, a region involved in mood regulation. The FDA first cleared TMS for major depressive disorder in 2008, according to the National Institute of Mental Health. It is delivered in an office, with no anesthesia and no medication.

‍

Our standard TMS course runs 20 to 30 daily sessions over four to six weeks, each 30 to 40 minutes long. You stay awake throughout and drive yourself home afterward. In real-world outcome data from 42 U.S. practices, more than half of patients with medication-resistant depression responded to a standard course, and more than a third reached remission.

What Is Ketamine Therapy?

Ketamine has been an FDA-approved anesthetic since 1970. Its use for depression is off-label: prescribed for a purpose the FDA has not formally approved, which is legal and common in medicine but leaves the safeguards less standardized. It is usually given as an IV infusion in a monitored clinic, as a series of sessions over a few weeks.

‍

Ketamine blocks the NMDA receptor, a glutamate receptor, rather than acting on serotonin like standard antidepressants, and that difference is thought to explain its speed. In a landmark 2006 trial, 18 people with treatment-resistant depression received a single infusion of 0.5 mg/kg, and their symptoms improved significantly within 110 minutes. By the next day, 71% had responded and 29% were in remission. One week later, 35% still met the response threshold. Rapid, real, and often short-lived.

‍

The catch is in the monitoring. Ketamine causes dissociation, a sense of detachment from your body or surroundings, plus sedation and blood pressure rises during and after the infusion, so you are observed until those effects pass and cannot drive that day. In a 2017 consensus statement in JAMA Psychiatry, an American Psychiatric Association task force found the evidence for rapid antidepressant effects convincing but the studies small, the longer-term efficacy data lacking, and the safety data on repeated dosing limited.

What Is Spravato (Esketamine)?

Ketamine is a mixture of two mirror-image molecules. Spravato is esketamine, one of those two, delivered as a nasal spray. Unlike IV ketamine, it has FDA approval for depression. The original approval came in March 2019 for treatment-resistant depression alongside an oral antidepressant, a second indication followed for adults with major depressive disorder and acute suicidal thoughts or behavior, and in January 2025 the FDA approved Spravato as a standalone monotherapy for treatment-resistant depression, with no oral antidepressant required, per the current prescribing information.

‍

That approval comes with a rulebook. Spravato can only be given at a setting certified under a Risk Evaluation and Mitigation Strategy (REMS) program: you take the spray under supervision, you are monitored for at least two hours before an assessment clears you to leave, and you cannot drive until the next day after a restful sleep. Its label carries a boxed warning for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors in younger patients.

‍

So is Spravato the same as ketamine? Related, not identical: same molecular family, same receptor, similar rapid onset and dissociative effects, but a different route, a formal FDA indication, and mandatory monitoring rules that off-label ketamine does not carry. For most people comparing TMS vs Spravato, those rules and insurance coverage are the practical differences that matter.

TMS vs Ketamine vs Spravato: Side-by-Side Comparison

Onset and Duration of Effect

Speed is the clearest dividing line. TMS builds gradually, and many people do not notice a clear change until the second or third week or later. Ketamine and Spravato can shift symptoms within hours to days.

‍

Speed and staying power are different things. Ketamine's effect after a single infusion often fades within a week or two, which is why it is given as a series with maintenance dosing. Spravato starts at twice a week and tapers, with the need for continued treatment reassessed along the way. Research on durability is still developing for all three, and none should be described as permanent.

Side Effects and Safety Considerations

TMS side effects are local and short-lived: scalp discomfort where the coil sits, headache, and sometimes brief lightheadedness or facial muscle twitching during the pulses. These usually settle within the first week, and because nothing enters the bloodstream there is no weight gain, sexual dysfunction, or sedation. Seizure is the one serious risk, exceedingly rare, and TMS is not used in people with a seizure history, metal in the head, or implanted electronic devices.

‍

Ketamine and Spravato share a different profile. The most common reactions to Spravato in trials were dissociation, dizziness, nausea, sedation, vertigo, numbness, anxiety, lethargy, increased blood pressure, vomiting, feeling drunk, and headache. Those effects peak in the hours after dosing, which is what the monitoring window is for, and both drugs carry a potential for misuse that shapes who is a candidate. Each option has its own screening, and a contraindication to one does not rule out the others.

Cost and Insurance

For TMS, most commercial insurers cover treatment for major depressive disorder once eligibility criteria are met, typically a confirmed diagnosis and documented antidepressant trials without adequate relief. Prior authorization is standard. For TMS we take all commercial insurance plans, cash pay is available, and authorization is something our intake team manages for you.

‍

Spravato is more commonly covered than off-label ketamine because it has an FDA indication insurers can write criteria around, though prior authorization and documentation of failed antidepressant trials are typically required. Ketamine infusion coverage varies widely, and many clinics are self-pay. Published cost estimates vary so much by dose, frequency, and insurance status that a single dollar figure would mislead; ask each provider and your insurer directly.

Can These Treatments Be Combined?

Sometimes, and the research is early. A 2024 systematic review found six published studies on combining TMS with ketamine, mostly case reports plus one retrospective review and one small pilot, and reported substantial and sustained improvement with generally mild side effects. The authors also said the designs were too varied and the samples too small for firm conclusions, and called for randomized trials.

‍

In practice, TMS and Spravato are sometimes used one after the other. Combining any of these is a clinical judgment a psychiatrist makes from your history, not a general recommendation, and the more common pattern is to use one, assess the response, then decide.

Choosing Between Them: What Influences the Decision

A psychiatrist weighing these options usually works through a short list:

‍

• Treatment history. Which antidepressants, at what doses, for how long, and whether psychotherapy has been tried.
• How urgently relief is needed. When symptoms are severe or suicidal thoughts are present, a faster-acting option may take priority, alongside care for suicidal thoughts.
• Tolerance for the experience. Dissociation and a two-hour monitored window, versus a daily half-hour appointment for several weeks with no drug effects.
• Practical constraints. Whether you can get to daily sessions, whether someone can drive you home after Spravato or ketamine, and what your insurance will authorize.
• Health factors. Seizure history, metal implants, blood pressure, and any history of substance misuse each rule options in or out.
• What else is in place. Any of the three works better inside ongoing psychiatric care and therapy than as a standalone fix.

Making the Decision With an Integrated Care Team

TMS, ketamine, and Spravato are tools, and tools do their best work inside a plan: a psychiatrist who knows your history, a therapist working alongside the biological treatment, and a team that notices when the plan needs to change.

‍

That is how we work. At Amae, our one-team care model combines psychiatry, therapy, primary care, and peer support, and TMS and Spravato are available through our Los Angeles and Bay Area clinics as part of that care. If you have been through the antidepressant cycle and want a clear, unhurried look at what comes next, talk with an Amae psychiatrist about your options. If you are in crisis or thinking about suicide, call or text 988 now.

Frequently Asked Questions

What is the difference between TMS and ketamine for depression?

TMS stimulates the brain with magnetic pulses over a course of daily outpatient sessions, with no drug, no sedation, and no monitoring afterward. Ketamine is a medication that acts on NMDA receptors, given by infusion or, as esketamine, by nasal spray, with monitored sedation and dissociation and often faster but shorter-lived effects.

Is Spravato the same as ketamine?

Related but not identical. Spravato is esketamine, the S-enantiomer of the ketamine molecule, delivered as an FDA-approved nasal spray under a required monitoring program. Ketamine infusions use the full ketamine compound and are prescribed off-label for depression, without an FDA indication for that use.

Is Spravato only approved with an antidepressant?

Not anymore. The original 2019 approval was for use alongside an oral antidepressant, and in January 2025 the FDA also approved Spravato as a standalone monotherapy for adults with treatment-resistant depression. Whether it is used alone or with an antidepressant is a decision your psychiatrist makes based on your situation.

Which works faster, TMS or Spravato?

Spravato. Esketamine and ketamine can produce symptom change within hours to days, while TMS builds gradually across a four-to-six-week course. Faster onset does not mean more durable improvement, and both durability and side effects belong in the comparison.

Can TMS and Spravato be used together?

Sometimes, as a clinical decision made with a psychiatrist based on your individual history. Both can be part of a broader treatment-resistant depression plan alongside medication and therapy, and the evidence on combining them is still early.

Is ketamine or Spravato covered by insurance?

Spravato is more commonly covered, because it has an FDA indication insurers can build criteria around, though prior authorization and proof of failed antidepressant trials are usually required. Coverage for off-label ketamine infusions varies widely and is often self-pay. Confirm with the provider and your insurer before starting.

‍

Citations

1. National Institute of Mental Health. Brain Stimulation Therapies. https://www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies (Tier 2)
2. Carpenter LL, Janicak PG, Aaronson ST, et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depression and Anxiety. 2012. https://pubmed.ncbi.nlm.nih.gov/22689344/ (Tier 1)
3. Zarate CA, Singh JB, Carlson PJ, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry. 2006. https://pubmed.ncbi.nlm.nih.gov/16894061/ (Tier 1)
4. Sanacora G, Frye MA, McDonald W, et al. A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry. 2017. https://pubmed.ncbi.nlm.nih.gov/28249076/ (Tier 1)
5. U.S. Food and Drug Administration. Drugs@FDA: SPRAVATO (esketamine), NDA 211243, approval history. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211243 (Tier 2)
6. U.S. Food and Drug Administration. SPRAVATO (esketamine) nasal spray prescribing information, revised January 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211243s016lbl.pdf (Tier 2)
7. Arubuolawe OO, Folorunsho IL, Busari AK, et al. Combination of transcranial magnetic stimulation and ketamine in treatment-resistant depression: a systematic review. Cureus. 2024. https://pubmed.ncbi.nlm.nih.gov/39156335/ (Tier 1, small-study review)
8. 988 Suicide and Crisis Lifeline. https://988lifeline.org (Tier 2)

‍

New York has no shortage of mental health clinics, but volume doesn’t simplify the decision. A public hospital system, a university faculty practice, and a specialized outpatient program are all called clinics, and they serve very different needs. What matters is matching the right type of provider to what you are actually dealing with.

Someone managing mild anxiety needs something very different from someone stabilizing after a first psychotic episode, and New York has clinics built for each. This guide organizes the city’s leading clinics by what they do, then walks through the provider types, levels of care, insurance, and practical steps to get started.

What to Look for in a Mental Health Clinic in NYC

Choosing among outpatient mental health options in NYC gets easier when you hold each clinic up against the same factors:

–  Evidence-based treatment. Look for established approaches: CBT, DBT, medication management, and structured programs like IOP and PHP when the situation calls for them.

–  Team composition. Who delivers care? Psychiatrists, licensed therapists (LCSW, LMHC), and peer support each play a different role. Integrated teams coordinate them.

–  Conditions treated. Some clinics handle complex and co-occurring conditions; others focus on general anxiety and depression. Match the clinic to your diagnosis.

–  Insurance acceptance. Confirm in-network status, and whether the clinic takes Medicaid or Medicare, before booking.

–  Wait times. These range from same-day appointments to months-long waitlists, especially at academic centers.

–  Integrated care. Some clinics coordinate psychiatry, therapy, and primary care under one roof, which matters most for serious or complex conditions where several providers would otherwise be working without talking to each other.

Best Mental Health Clinics in NYC

New York’s clinics fall into distinct categories, each built for a different need: integrated care for serious mental illness, academic medical centers, public safety-net systems, private outpatient practices, and nonprofit community clinics. The best clinic is the one whose category fits your situation, so the providers below are grouped that way rather than ranked against each other. Start by finding the category that matches what you are dealing with, then compare the specifics of insurance, location, and wait time within it.

Details were verified from each provider as of 2026; confirm current specifics directly, since programs and insurance networks change.

Amae Health: Integrated Care for Adult Severe Mental Illness

At our Upper East Side clinic, Amae Health provides integrated outpatient care for adults living with severe and complex mental illness, delivered in collaboration with NewYork-Presbyterian. We treat depression, bipolar disorder, schizophrenia, schizoaffective disorder, PTSD, and co-occurring conditions.

The difference is the team, not any single service. Every patient works with a coordinated group under one roof: psychiatrists, therapists, peer support specialists, health coaches, and primary care. Rather than juggling separate providers who never speak to each other, you work with one team and one treatment plan — which matters most when a condition touches several parts of life at once.

–  Specialties: Depression, bipolar disorder, schizophrenia, schizoaffective disorder, PTSD, co-occurring conditions

–  Care model: Integrated psychiatry, therapy, peer support, and primary care

–  Insurance: Healthfirst, Fidelis Care, and Wellcare; same-day appointments available

–  Best for: Adults with serious or complex mental illness who want fully integrated, psychiatrist-led care

NewYork-Presbyterian: Academic Medical Center Care

NewYork-Presbyterian provides adult outpatient psychiatry through its Weill Cornell and Columbia campuses, covering anxiety, bipolar disorder, depression, and psychosis. For treatment-resistant depression, it offers interventional options including TMS and ketamine. NewYork-Presbyterian-Columbia and Cornell was ranked #3 in the nation for psychiatry by U.S. News & World Report in 2025 (U.S. News Best Hospitals for Psychiatry). Waitlists can be longer.

–  Specialties: Mood, anxiety, and psychotic disorders; treatment-resistant depression

–  Care model: Academic hospital outpatient care with interventional psychiatry

–  Best for: Patients who want academic-center expertise and can wait for intake

ColumbiaDoctors: University Faculty Practice

ColumbiaDoctors is Columbia University’s psychiatry and psychology faculty practice, one of the largest mental health providers in the New York metro area with over 100 clinicians. Beyond standard outpatient care, it runs specialized programs, including the Columbia Day Program, an intensive outpatient clinic in Midtown, a dedicated DBT program, and the Lieber Recovery Clinic for adults with schizophrenia spectrum and other complex conditions.

–  Specialties: Complex and psychotic disorders, emotion dysregulation, substance use

–  Care model: University faculty practice with specialized outpatient and day programs

–  Best for: Patients seeking subspecialty academic care or a specific program like DBT

NYC Health + Hospitals: Public Safety-Net Care

NYC Health + Hospitals is the city’s largest public health system and its largest behavioral health provider, delivering the majority of mental health and substance use care in New York City. Services run across emergency, inpatient, and outpatient settings at public hospitals citywide, including Bellevue, Metropolitan, Elmhurst, and Lincoln, plus a 24/7 Behavioral Health Virtual ExpressCare line for urgent, non-emergency needs.

–  Specialties: The full range of mental health and substance use conditions

–  Care model: Public hospital system, care regardless of immigration status or ability to pay

–  Insurance: Accepts Medicaid; sees all patients regardless of coverage

–  Best for: New Yorkers who need public, low-cost, or uninsured-friendly care

Integrative Psych: Private Outpatient and Ketamine-Assisted Therapy

Integrative Psych is a private Manhattan practice offering psychiatry and therapy for anxiety, depression, ADHD, OCD, and trauma. It combines medication management with evidence-based modalities including CBT, DBT, and EMDR, and offers ketamine-assisted therapy for conditions that have not responded to conventional treatment. An initial consultation precedes any treatment commitment.

–  Specialties: Anxiety, depression, ADHD, OCD, trauma

–  Care model: Private outpatient therapy and psychiatry, with ketamine-assisted therapy

–  Best for: Adults seeking private outpatient care or interventional options for treatment-resistant symptoms

Metropolitan Center for Mental Health: Nonprofit Community Care

Metropolitan Center for Mental Health is a nonprofit outpatient organization founded in 1962, with three Manhattan locations, including Central Park West and Washington Heights. It provides individual, family, couples, and group therapy plus medication management, with a longstanding focus on affordable, community-based care.

–  Specialties: General outpatient mental health across a broad range of conditions

–  Care model: Nonprofit community outpatient clinic

–  Insurance: Accepts Medicaid and Medicare, with sliding-scale fees for the uninsured

–  Best for: New Yorkers seeking affordable, community-based outpatient therapy

Types of Mental Health Providers in NYC

Different providers do different things. Knowing the distinction helps you find the right support faster.

Psychiatrists

Psychiatrists are board-certified physicians who have completed a psychiatry residency. They diagnose mental health conditions, prescribe and manage medication, and sometimes provide therapy. No referral is required to see one. For serious conditions, psychiatric oversight anchors the treatment plan.

Therapists (LCSW, LMHC, Psychologist)

Therapists provide talk therapy, including CBT, DBT, and psychodynamic approaches, but cannot prescribe medication. Many people work with both a therapist and a psychiatrist. Some clinics coordinate the two under one team so the therapy and the medication plan inform each other.

Psychiatric Nurse Practitioners (PMHNP)

Psychiatric-mental health nurse practitioners can diagnose and prescribe in New York State. They often work alongside psychiatrists in integrated care teams, expanding access to evaluation and medication management.

Conditions Treated at Mental Health Clinics in NYC

Most outpatient clinics treat a range of conditions, though some specialize:

–  Major Depressive Disorder. For treatment-resistant cases, a larger academic center or a depression treatment center in New York may offer TMS or ketamine when standard antidepressants have not worked.

–  Bipolar disorder. Best managed at integrated clinics with coordinated psychiatry and therapy.

–  Anxiety disorders, including generalized anxiety, panic, social anxiety, and OCD.

–  PTSD and trauma. Look for clinicians trained in Cognitive Processing Therapy, EMDR, or Prolonged Exposure.

–  Schizophrenia, schizoaffective disorder, and first-episode psychosis. These benefit from specialized IOP programs and structured psychiatric support.

–  Co-occurring conditions. Mental health and substance use are best treated together by an integrated care team rather than in separate silos.

Levels of Outpatient Mental Health Care in New York

Outpatient care comes at different intensities depending on symptoms and support needs.

Standard Outpatient

Usually one session per week with a therapist or psychiatrist. Suited to people managing symptoms while functioning in daily life.

Intensive Outpatient Program (IOP)

Around three days per week, roughly three hours per session, combining group therapy, individual therapy, and psychiatric management. IOP fits people who need more support than weekly sessions.

Partial Hospitalization Program (PHP)

Up to five days per week for several hours per day. SAMHSA defines partial hospitalization as ambulatory care delivered more than three hours per day on more than two days per week (SAMHSA, N-SUMHSS Definitions). PHP is used as a step-down from inpatient care or for acute symptoms. Not every clinic offers it.

CBT and DBT run through all of these levels; both are among the best-studied psychotherapies for mood, anxiety, and emotion-regulation conditions (NIMH, Psychotherapies).

How to Find the Right Mental Health Clinic in NYC

A practical sequence:

1.  Identify what you need. Medication, therapy, or both? Your symptoms and daily functioning point to the level of care.

2.  Check insurance before booking. Confirm in-network status and your copay.

3.  Search by condition, insurance, and location. The Psychology Today therapist directory and SAMHSA’s FindTreatment.gov locator both filter on all three.

4.  Verify the provider’s license. The New York State Office of the Professions lets you confirm a clinician is licensed and in good standing.

5.  Ask about first available appointments. A shorter path to care matters when symptoms are acute.

If you want help thinking through which level of care fits, contact our team.

How Much Does Mental Health Treatment Cost in NYC?

Cost depends heavily on insurance. Under the federal Mental Health Parity and Addiction Equity Act, plans that cover mental health must apply financial terms no more restrictive than those for medical care (CMS, MHPAEA).

With insurance: most plans, including Medicaid and Medicare, cover outpatient mental health. In-network copays typically run $0 to $50 per session.

Without insurance: psychiatrist sessions often run $300 to $500 and therapy $150 to $300, as general ranges rather than quotes. NYC Health + Hospitals and Federally Qualified Health Centers see patients regardless of ability to pay, often on a sliding scale.

Out-of-network: ask the provider for a superbill, a detailed receipt you submit to your insurer for partial reimbursement. Reimbursement rates vary widely by plan, so it helps to ask your insurer what percentage of an out-of-network mental health visit they cover before committing. Our patients and families resources can help you prepare. Confirm every figure with the clinic and your insurer before you begin.

Getting Started

Finding the right clinic is the first step, and it does not have to be the hardest one. If you or someone you love is managing a serious or complex mental health condition, Amae Health’s NYC clinic offers integrated care with psychiatry, therapy, peer support, and primary care under one team, in collaboration with NewYork-Presbyterian. Explore our full range of treatments, or call to talk with our intake team about whether Amae is the right fit for your situation.

Frequently Asked Questions

–  What is the best mental health clinic in NYC? There is no single best clinic; it depends on your condition, the support you need, your insurance, and your location. For complex or serious conditions, Amae Health offers integrated psychiatric care on the Upper East Side. For general therapy or academic subspecialty care, a private practice or university clinic may fit better.

–  What is the difference between a psychiatrist and a therapist? Psychiatrists are medical doctors who diagnose and prescribe medication; therapists provide talk therapy but cannot prescribe. Many people work with both, and some clinics coordinate the two roles under one team.

–  Does insurance cover mental health treatment in NYC? Yes. Most plans, including Medicaid and Medicare, cover outpatient mental health, and parity law requires that coverage to be comparable to medical care. Confirm your copay and in-network status with your insurer before scheduling.

–  What is outpatient mental health treatment? Outpatient treatment is psychiatric care or therapy you receive while living at home. It ranges from weekly standard sessions to more intensive IOP and PHP programs for people who need more structure.

–  How long does it take to get a mental health appointment in NYC? It varies. Hospital systems and academic centers often have longer waitlists, while some clinics offer same-day appointments, including Amae Health. For free 24/7 support, contact NYC 988 by phone, text, or chat at 988.

–  Can I get mental health treatment in NYC without insurance? Yes. NYC Health + Hospitals sees all patients regardless of ability to pay, Federally Qualified Health Centers offer sliding-scale fees, and Medicaid enrollment is open to eligible New Yorkers.

–  What conditions do outpatient mental health clinics in NYC treat? Depression, anxiety, bipolar disorder, PTSD, OCD, schizophrenia, schizoaffective disorder, and co-occurring conditions. Specialties vary by clinic, so confirm a clinic’s experience with your diagnosis before booking.

Citations

1. SAMHSA, National Substance Use and Mental Health Services Survey (N-SUMHSS) Definitions: “Partial hospitalization/day treatment.” info.nsumhss.samhsa.gov/definitions.htm. Tier 2 (U.S. government).

2. National Institute of Mental Health, “Psychotherapies.” nimh.nih.gov/health/topics/psychotherapies. Tier 2 (U.S. government).

3. Centers for Medicare & Medicaid Services, “The Mental Health Parity and Addiction Equity Act (MHPAEA).” cms.gov. Tier 2 (U.S. government).

4. U.S. News & World Report, “Best Hospitals for Psychiatry in New York.” health.usnews.com. Tier 4 (reputable ranking).

‍

Most people comparing TMS vs medication for depression arrive at the question the same way: the antidepressants have not brought enough relief. If that is you, it helps to know that both are evidence-based, FDA-cleared treatments, and they work in completely different ways. Medication adjusts brain chemistry from the inside. TMS stimulates the brain directly with magnetic pulses. Neither is universally better. The right choice depends on your treatment history, the severity of your symptoms, how you tolerate side effects, and your own preferences, especially once you are dealing with treatment-resistant depression or trying to figure out what to do when antidepressants don't work. This article compares the two fairly, not to push one over the other.

How Antidepressants Work

Antidepressants change the availability of certain brain chemicals, mainly serotonin and norepinephrine, that influence mood. The most common are SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors). Both are considered first-line treatment, meaning they are usually where a clinician starts.

‍

They are taken daily as a pill at home, and they work gradually. Most people need several weeks before the full effect shows, which is one of the harder parts of starting an antidepressant: you often have to wait to know whether it is working. Finding the right medication and dose regularly takes some trial and adjustment, and a first medication that does not help does not mean none will. There are many options within each class, so a clinician can switch or fine-tune based on how a person responds. Older tricyclic antidepressants (TCAs) also work but tend to cause harsher side effects, so they are usually reserved for later steps rather than first-line use. The main appeal of medication is convenience and evidence: it is taken at home, it is inexpensive, and it has decades of research behind it.

How TMS Works

Transcranial magnetic stimulation (TMS) is a non-invasive treatment that uses focused magnetic pulses, similar in strength to an MRI, to stimulate the mood-regulating areas of the brain that tend to be underactive in depression, mainly the left dorsolateral prefrontal cortex. It is FDA-cleared for major depressive disorder in adults, and also for OCD (NIMH, Brain Stimulation Therapies).

‍

TMS is not electroconvulsive therapy (ECT). There is no anesthesia and no sedation, and the patient stays fully awake through each session, then drives home and returns to normal activity. During a session, a coil rests against the scalp and delivers pulses in short cycles, which most people feel as a tapping sensation. A typical course runs about five days a week for several weeks, with each session lasting under an hour, and the benefit tends to build gradually across the course rather than after any single visit.

‍

As a non-drug option, TMS is one of the main alternatives to antidepressants for people whose medication has stopped short. It usually works best as part of a broader treatment plan, coordinated with therapy and, in many cases, ongoing medication, rather than as a replacement for all other care.

TMS vs Medication: Side-by-Side Comparison

The two treatments differ on almost every practical dimension, from how they are delivered to how quickly they work and what they ask of you day to day. The table below lays the key differences side by side, and the sections that follow unpack the two that matter most to people making this decision: side effects and success rates.

Side Effects Compared

Antidepressant side effects vary by class. SSRIs commonly cause weight gain and sexual dysfunction, though some effects ease after the first few weeks. SNRIs have a similar profile that is often milder. TCAs tend to be harsher, which is why they are rarely a first choice. These are systemic effects, because the medication acts throughout the body.

‍

TMS side effects are usually mild and short-lived: scalp discomfort, headache, or lightheadedness that typically passes soon after a session and lessens over the first week. The most serious risk, seizure, is very rare. Because TMS is non-invasive and targeted rather than systemic, it avoids the weight, sexual, and sleep side effects associated with medication, and it does not affect memory or cognition the way some people fear based on older brain treatments like ECT.

‍

It is not side-effect-free, though, and its main practical downside is different in kind. Instead of a daily side effect, TMS asks for a time commitment: traveling to a clinic most weekdays for several weeks. For someone with a demanding schedule or limited transportation, that logistical cost is real and worth weighing against the appeal of avoiding medication side effects. Neither profile is automatically easier to live with; they are simply different, and which one fits depends on the person.

Success Rates: What the Research Shows

Both treatments help many people, and neither helps everyone. Reading the numbers honestly matters more than cheerleading for either one. Two terms come up often: response means a meaningful reduction in symptoms, usually cutting them roughly in half, while remission means symptoms largely resolve. Remission is the higher bar and the real goal.

‍

For medication, the landmark STAR*D study found that roughly a third of patients reached remission on their first SSRI (Trivedi et al., American Journal of Psychiatry, 2006). That is a genuinely useful result for many people. But it also means most did not remit on the first try, and STAR*D showed that with each additional medication tried after a failure, the odds of remission tend to drop while side-effect burden tends to rise. That diminishing return is exactly the situation that leads people to look at other options.

‍

For TMS, a large real-world registry of more than 5,000 patients found that most experienced measurable improvement, with response rates ranging from about 58% to 83% and remission from about 28% to 62%, depending on how outcomes were measured (Sackeim et al., Journal of Affective Disorders, 2020). The wide ranges are worth noting: they reflect different rating scales and patient groups, and many of those patients were also taking medication, so the numbers describe TMS in real-world use rather than in isolation.

‍

For treatment-resistant depression specifically, a 2024 randomized trial compared TMS with switching or augmenting medication in 89 people who had not responded to at least two antidepressants, with both groups also receiving psychotherapy. The TMS group had significantly higher response and remission rates than the medication group (Dalhuisen et al., American Journal of Psychiatry, 2024). It is one of the clearest head-to-head comparisons available, though individual results always vary, and these figures describe groups, not guarantees for any one person.

When Antidepressants Don't Work: Where TMS Fits

About a third of people with major depressive disorder do not respond adequately to first-line treatment, a pattern clinicians call treatment-resistant depression. It is not a sign of personal failure or a rare edge case; it is common, and it has its own growing set of treatment options. When two or more medications have failed, or when side effects are intolerable, TMS becomes a well-supported next step, and the 2024 trial above is part of why it is increasingly positioned early in the treatment-resistant pathway rather than as a last resort.

‍

TMS is not the only option at this stage. Spravato (esketamine), a nasal spray derived from ketamine, is FDA-approved for treatment-resistant depression when used together with an oral antidepressant. It is given in a certified clinic under medical supervision, with monitoring after each dose, because of its dissociative effects. Combining TMS with an antidepressant is another route, and research suggests the combination can improve outcomes over medication alone. The larger point is that once first-line medication falls short, the path forward branches into several evidence-based options, and those branches are not mutually exclusive. A person might use medication and TMS together, or move from one approach to another as their psychiatrist learns what their brain responds to.

Who Is Each Treatment For?

Medication is often the right starting point for someone who is:

‍

• Early in treatment for depression
• Managing mild to moderate symptoms
• Looking to avoid in-clinic visits
• Someone who has responded well to an antidepressant before

‍

TMS is generally considered for someone who:

‍

• Has tried multiple antidepressants without adequate relief
• Cannot tolerate medication side effects
• Prefers a non-drug approach
• Has treatment-resistant depression

‍

Many people use both at different points, and some use them together. Where a person lands is a clinical decision, not a solo consumer choice, and it belongs with a psychiatrist who knows the full history.

Making the Decision With a Psychiatrist

TMS, medication, Spravato, and therapy are not competing products. They are tools a psychiatrist combines and adjusts based on diagnosis, history, and how a person responds over time. Comparing TMS and medication on paper is useful, but the decision is rarely either-or, and it is rarely one-and-done. It usually looks more like a sequence: start somewhere reasonable, measure the response, and adjust. The most reliable way to navigate that sequence, and to change course when needed, is a thorough evaluation within an integrated care setting, where the clinician managing your medication is the same one weighing whether TMS or another option fits.

‍

That is how care works at Amae Health. Our psychiatry-led teams evaluate the whole picture and coordinate treatment across medication, therapy, and procedures like TMS, which we offer at our Los Angeles clinic. You can explore our full range of treatments or, for severe depression that needs more structure, our Partial Hospitalization Program. Our resources for patients and families explain how integrated care works, and you can contact our team to ask about an evaluation.

Frequently Asked Questions

Is TMS better than medication for depression? Neither is universally better. Medication is first-line and works well for many people. For treatment-resistant depression, where two or more medications have failed, TMS often outperforms a medication switch. The right choice depends on history, severity, and side-effect tolerance.

‍

Can you do TMS and take antidepressants at the same time? Yes. TMS can be combined with antidepressants, and research suggests the combination can improve outcomes compared with medication alone. This should be coordinated by a psychiatrist.

‍

What are the side effects of TMS vs medication? TMS side effects are usually mild and short-lived, mainly scalp discomfort or headache that fades after the first week. Medication side effects vary but can include weight change, sexual dysfunction, and fatigue. Because it is non-invasive, TMS avoids the systemic side effects of medication.

‍

Does TMS work when antidepressants don't? Often, yes. TMS is specifically supported for treatment-resistant depression. A 2024 randomized trial found higher response and remission rates with TMS than with switching medications after failed trials. Individual results vary.

‍

How long does TMS treatment take? A typical course is sessions about five days a week for several weeks, each lasting under an hour. Antidepressants, by contrast, are taken daily and may take several weeks to show their full effect.

‍

What if neither TMS nor medication works? Other options exist, including Spravato (esketamine) used with an oral antidepressant, combination approaches, and structured programs like IOP or PHP for severe depression. A psychiatrist can help identify next steps. Depression is hard, and support is available: if you are struggling, call or text the 988 Suicide and Crisis Lifeline at 988, anytime.

‍

Citations

1. Trivedi MH, Rush AJ, Wisniewski SR, et al. "Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D." American Journal of Psychiatry, 2006. psychiatryonline.org. Tier 1 (peer-reviewed).
2. Sackeim HA, Aaronson ST, Carpenter LL, et al. "Clinical outcomes in a large registry of patients with major depressive disorder treated with transcranial magnetic stimulation." Journal of Affective Disorders, 2020. sciencedirect.com. Tier 1 (peer-reviewed).
3. Dalhuisen I, van Oostrom I, Spijker J, et al. "rTMS as a Next Step in Antidepressant Nonresponders: A Randomized Comparison With Current Antidepressant Treatment Approaches." American Journal of Psychiatry, 2024. PubMed 39108161. Tier 1 (peer-reviewed RCT).
4. National Institute of Mental Health, "Brain Stimulation Therapies." nimh.nih.gov. Tier 2 (U.S. government).

‍

Further reading (external resources): NIMH, Depression; Mayo Clinic, Transcranial Magnetic Stimulation.

‍